Axel Muendlein

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

International journal of molecular sciences

Scientific reports

European heart journal open

Journal of clinical medicine

Vorarlberg Institute for Vascular Investigation and Treatment

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vorarlberg Institute for Vascular Investigation and Treatment Feb 01 2005

Austria

Head of Laboratory :: Molecular Laboratory

Publications

Andreas Leiherer, Axel Muendlein, Sylvia Mink, Arthur Mader, Christoph H Saely, Andreas Festa, Peter Fraunberger, Heinz Drexel
Machine Learning Approach to Metabolomic Data Predicts Type 2 Diabetes Mellitus Incidence. International journal of molecular sciences 25 (10) (2024)
Andreas Leiherer, Axel Muendlein, Sylvia Mink, Arthur Mader, Christoph H Saely, Andreas Festa, Peter Fraunberger, Heinz Drexel
Machine Learning Approach to Metabolomic Data Predicts Type 2 Diabetes Mellitus Incidence. International journal of molecular sciences 25 (10) (2024)
Andreas Leiherer, Axel Muendlein, Christoph H Saely, Reijo Laaksonen, Peter Fraunberger, Heinz Drexel
Ceramides improve cardiovascular risk prediction beyond low-density lipoprotein cholesterol. European heart journal open 4 (1) (2024)
Andreas Leiherer, Axel Muendlein, Christoph H Saely, Reijo Laaksonen, Peter Fraunberger, Heinz Drexel
Ceramides improve cardiovascular risk prediction beyond low-density lipoprotein cholesterol. European heart journal open 4 (1) (2024)
Andreas Leiherer, Axel Muendlein, Sylvia Mink, Arthur Mader, Christoph H Saely, Andreas Festa, Peter Fraunberger, Heinz Drexel
Machine Learning Approach to Metabolomic Data Predicts Type 2 Diabetes Mellitus Incidence. International journal of molecular sciences 25 (10) (2024)
Axel Muendlein, Kathrin Geiger, Christine Heinzle, Stella Gaenger, Thomas Winder, Luciano Severgnini, Patrick Reimann, Eva Maria Brandtner, Andreas Leiherer, Heinz Drexel, Thomas Decker, Christoph Nonnenbroich, Tobias Dechow
Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients. Journal of cancer research and clinical oncology (2023)
Andreas Leiherer, Axel Muendlein, Christoph H Saely, Kathrin Geiger, Eva-Maria Brandtner, Christine Heinzle, Stella Gaenger, Sylvia Mink, Reijo Laaksonen, Peter Fraunberger, Heinz Drexel
Coronary Event Risk Test (CERT) as a Risk Predictor for the 10-Year Clinical Outcome of Patients with Peripheral Artery Disease. Journal of clinical medicine 12 (19) (2023)
Axel Muendlein, Christine Heinzle, Eva Maria Brandtner, Andreas Leiherer, Kathrin Geiger, Stella Gaenger, Heinz Drexel, Tobias Dechow, Thomas Decker
Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patients. Breast cancer research and treatment (2023)
Axel Muendlein, Eva Maria Brandtner, Andreas Leiherer, Kathrin Geiger, Christine Heinzle, Stella Gaenger, Peter Fraunberger, Dominik Haider, Christoph H Saely, Heinz Drexel
Evaluation of the association of serum glypican-4 with prevalent and future kidney function. Scientific reports 12 (1) (2022)
Daria Slefarska, Christine Heinzle, Andreas Leiherer, Clemens Ager, Axel Muendlein, Linda Mezmale, Marcis Leja, Alejandro H Corvalan, Heinz Drexel, Agnieszka Królicka, Gidi Shani, Christopher A Mayhew, Hossam Haick, Paweł Mochalski
Volatilomic Signatures of AGS and SNU-1 Gastric Cancer Cell Lines. Molecules (Basel, Switzerland) 27 (13) (2022)
Axel Muendlein, Kathrin Geiger, Stella Gaenger, Tobias Dechow, Christoph Nonnenbroich, Andreas Leiherer, Heinz Drexel, Andreas Gaumann, Wolfgang Jagla, Thomas Winder, Frank Mayer, Thomas Decker
Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patients. Scientific reports 11 (1) (2021)
Kathrin Geiger, Christina Zach, Andreas Leiherer, Peter Fraunberger, Heinz Drexel, Axel Muendlein
Real-time PCR based HLA-B*27 screening directly in whole blood. HLA 95 (3) (2019)

Axel Muendlein.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Axel Muendlein